The expression of SEL1L and TAN-1 in normal and neoplastic cells

被引:17
作者
Cattaneo, M
Orlandi, R
Ronchini, C
Granelli, P
Malferrari, G
Menard, S
Biunno, I
机构
[1] Natl Res Council, Inst Adv Biomed Technol, Milan, Italy
[2] Natl Canc Inst, Dept Expt Oncol, Mol Targeting Unit, I-20133 Milan, Italy
[3] Univ Milan, Osped Maggiore, IRCCS, Dept Gen Surg & Surg Oncol, Milan, Italy
关键词
SEL1L and TAN-1expression; neoplastic cells;
D O I
10.1177/172460080001500105
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have previously reported on the isolation and chromosomal mapping of a novel human gene (SELIL), which shows sequence similarity to sel-1, an extragenic suppressor of C. elegans. sel-1 functions as a negative regulator of lin-12 activity, the latter being implicated in the control of diverse cellular differentiation events. In the present study we compare the expression patterns of SELIL, and TAN-I, the human ortholog of lin-12 in normal and neoplastic cells. We found that whereas both genes are expressed in fetal tissues at similar levels, they are differentially expressed in normal adult and neoplastic cells. In normal adult cells SELIL is generally present at very low levels; only in the cells of the pancreas does it show maximum expression, By contrast SELIL is generally well represented in most neoplastic cells but not in those of pancreatic and gastric carcinomas, where transcription is either downregulated or completely repressed. TAN-I on the other hand is well represented in almost all normal and neoplastic cells, with very few exceptions. Our observations suggest that SELIL is presumably implicated in pancreatic and gastric carcinogenesis and that, along with TAN-I, it is very important for normal cell function. Alterations in the expression of SELIL may be used as a prognostic marker for gastric and pancreatic cancers.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 31 条
  • [1] Notch signalling controls pancreatic cell differentiation
    Apelqvist, Å
    Li, H
    Sommer, L
    Beatus, P
    Anderson, DJ
    Honjo, T
    de Angelis, MH
    Lendahl, U
    Edlund, H
    [J]. NATURE, 1999, 400 (6747) : 877 - 881
  • [2] Notch signaling: Cell fate control and signal integration in development
    Artavanis-Tsakonas, S
    Rand, MD
    Lake, RJ
    [J]. SCIENCE, 1999, 284 (5415) : 770 - 776
  • [3] NOTCH SIGNALING
    ARTAVANISTSAKONAS, S
    MATSUNO, K
    FORTINI, ME
    [J]. SCIENCE, 1995, 268 (5208) : 225 - 232
  • [4] Isolation of a pancreas-specific gene located on human chromosome 14q31: Expression analysis in human pancreatic ductal carcinomas
    Biunno, I
    Appierto, V
    Cattaneo, M
    Leone, BE
    Balzano, G
    Socci, C
    Saccone, S
    Letizia, A
    DellaValle, G
    Sgaramella, V
    [J]. GENOMICS, 1997, 46 (02) : 284 - 286
  • [5] BIUNNO I, IN PRESS HUMAN GENET
  • [6] Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2
    Capobianco, AJ
    Zagouras, P
    Blaumueller, CM
    ArtavanisTsakonas, S
    Bishop, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) : 6265 - 6273
  • [7] The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions
    Daniel, B
    Rangarajan, A
    Mukherjee, G
    Vallikad, E
    Krishna, S
    [J]. JOURNAL OF GENERAL VIROLOGY, 1997, 78 : 1095 - 1101
  • [8] Cloning and characterization of Sel-11, a murine homolog of the C-elegans sel-1 gene
    Donoviel, DB
    Donoviel, MS
    Fan, E
    Hadjantonakis, AK
    Bernstein, A
    [J]. MECHANISMS OF DEVELOPMENT, 1998, 78 (1-2) : 203 - 207
  • [9] SEL-1L maps to human chromosome 14, near the insulin-dependent diabetes mellitus locus 11
    Donoviel, DB
    Bernstein, A
    [J]. GENOMICS, 1999, 56 (02) : 232 - 233
  • [10] TAN-1, THE HUMAN HOMOLOG OF THE DROSOPHILA NOTCH GENE, IS BROKEN BY CHROMOSOMAL TRANSLOCATIONS IN T-LYMPHOBLASTIC NEOPLASMS
    ELLISEN, LW
    BIRD, J
    WEST, DC
    SORENG, AL
    REYNOLDS, TC
    SMITH, SD
    SKLAR, J
    [J]. CELL, 1991, 66 (04) : 649 - 661